صفحه 1:
it 0
0 ۱
۳ ۳ i i
€ »)))
صفحه 2:
صفحه 3:
خب ۱7
® Vasculitis is a clinicopathologic process
characterized by inflammationof and damage
to blood vessels.
صفحه 4:
a
Secondary Vasculitis Syndromes
Vasculitis associated with probable
etiology
Dru
Hepatitis C virus-associated
cryoglobulinemic vasculitis
Hepatitis B virus-associated
vasculitis
induced vasculitis
Cancer-associated vasculitis
Vasculitis associated with systemic
disease
Lupus vasculitis
Rheumatoid vasculitis
Sarcoid vasculitis
La
Primary Vasculitis Syndromes
Granulomatosis with polyangiitis
(Wegener's)
Microscopic polyangiitis
Eosinophilic granulomatosis with
polyangiitis (Churg-Strauss)
IgA vasculitis (Henoch-Schontein)
Cryoglobulinemic vasculitis
Polyarteritis nodosa
Kawasaki disease
Giant cell arteritis
Takayasu arteritis
Behcet's disease
Cogan’s syndrome
Single-organ vasculitis
Cutaneous leukocytoclastic angiitis
Cutaneous arteritis
Primary central nervous system
vasculitis
Isolated aortitis
صفحه 5:
eS
4 ۱۱۱۱3 ور POTENTIAL MECHANISMS OF VESSEL DAMAGE IN
VASCULITIS SYNDROMES
Pathogenic immune-complex formation and/or deposition
IgA vasculitis (Henoch-Schénlein)
Lupus vasculitis
Serum sickness and cutaneous vasculitis syndromes
Hepatitis C virus-associated cryoglobulinemic vasculitis
Hepatitis B virus-associated vasculitis
Production of antineutrophilic cytoplasmic antibodies
Granulomatosis with polyangiitis (Wegener's)
Microscopic polyangiitis
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
Pathogenic T lymphocyte responses and granuloma formation
Giant cell arteritis
Takayasu arteritis
Granulomatosis with polyangiitis (Wegener's)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
صفحه 6:
ee
ai سس
APPROACH TO THE PATIENT:
general principles of Diagnosis
® unexplained systemic illness
© palpable purpura
© pulmonary infiltrates
® microscopic hematuria,
© chronic inflammatory sinusitis,
® mononeuritis multiplex,
® unexplained ischemic events
© glomerulonephritis with evidence of
multisystem disease.
صفحه 7:
© the first step in the workup of a patient with
suspected vasculitis is to exclude other
diseases that produce clinical manifestations
that can mimic vasculitis
® a series of progressive steps that establish
the diagnosis of vasculitis and determine,
where possible, the category of the vasculitis
syndrome
صفحه 8:
خب ۱7
® The yield of “blind” biopsies of organs with
no subjectiveor objective evidence of
involvement is very low and should be
avoided.
® When syndromes such as polyarteritis
nodosa, Takayasu arteritis, or primary
central nervous system (CNS) vasculitis are
suspected, arteriogram of organs with
suspected involvement should be performed.
صفحه 9:
‘Atheroembolc disease
‘Antiglomerular basement membrane disease (Goodpasture's synciome)
‘Amyloidosis
Migraine
يي ل ۰
صفحه 10:
© If an offending antigen that precipitates the
vasculitis is recognized, the antigen should be
removed where possible
© If the vasculitis is associated with an
underlying disease
such as an infection, neoplasm, or connective
tissue disease, the
underlying disease should be treated
صفحه 11:
خب ۱7
® glucocorticoids and/or cytotoxic therapy
should be instituted immediately in diseases
where irreversible organ system dysfunction
and high morbidity and mortality rates have
been clearly established
® Granulomatosis with polyangiitis (Wegener's)
is the prototype of a severe systemic
vasculitis requiring such a therapeutic
approach
صفحه 12:
© On the other hand, when feasible, aggressive
therapy should be avoided for vasculitic
manifestations that rarely result in
irreversible organ system dysfunction and
that usually do not respond to such therapy
© For example, idiopathiccutaneous vasculitis
صفحه 13:
خب ۱7
® Glucocorticoids should be initiated in those
systemic vasculitides that cannot be
specifically categorized or for which there is
no established standard therapy; cytotoxic
therapy should be added in these diseases
only if an adequate response does not result
or if remission can only be achieved and
maintained with an unacceptably toxic
regimen of glucocorticoids
صفحه 14:
خب ۱7
© When remission is achieved, one should
continually attempt to taper glucocorticoids
and discontinue when possible
© Methotrexate and azathioprine are also
associated with bone marrow suppression,
and complete blood counts should be
obtained every 1-2 weeks for the first 1-2
months after their initiation and once a
month thereafter.
صفحه 15:
خب ۱7
® To lessen toxicity, methotrexate is often given
together with folic acid
© With the use of daily cyclophosphamide:
© minimization of bladder toxicity and
prevention of leukopenia
صفحه 16:
© Bladder cancer can occur several years after
discontinuation of cyclophosphamide therapy
© Bone marrow suppression is an important
toxicity of cyclophosphamide
© Maintaining the white blood count (WBC) at
>3000/L and the neutrophil count >1500/L
صفحه 17:
خب ۱7
GPagraonbinsat oul Paseulitis ofWheampper and
lower respiratory tracts together with
glomerulonephritis
© the mean age of onset is 40 years.
® The histopathologic hallmarks of
granulomatosis with polyangiitis (Wegener's)
are necrotizing vasculitis of small arteries
and veins together with granuloma formation
صفحه 18:
خب ۱7
© Lung involvement typically appears as
multiple, bilateral, nodular cavitary infiltrates
صفحه 19:
صفحه 20:
HIGURE386e-2 Computed tomography of the chest in two patients with grenuiomatesis with polyangitis (Wegener) demonstrating
(@)single and (8) mutipie cavitary lung lesions,
صفحه 21:
A
FIGURE386e33 Bilateral ground-glass infiltrates Cue to alveolar hemorrhage from pulmonary capilaits as seen in the same patient by
(A) chest radiograph and (B) computed tomography. This manifestation can occur in granulomatosis with polyangits (Wegener's) or micio-
scopic polyanait.
صفحه 22:
HIGURE 286e1 Bilateral nedular infiltrates seen on computed tomography of the ches: ina 40 year old woman with granulomatosis with
polyangitis Wegeners).
صفحه 23:
FIGURE 386e-4 Computed tomography of the chest de
صفحه 24:
FIGURE 3866-5 ۳ tomography of the orbits
with granulomatosis / ٩۱8۲ 5( ۵
monstrates inflamr
jid sinus through the lamina p
right-ey
ding f
filing
صفحه 25:
صفحه 26:
خب ۱7
© Granuloma formation is only rarely seen on
renal biopsy
صفحه 27:
۳ a i
i 0 ا
صفحه 28:
® Involvement of the upper airways occurs in
95% of patients with granulomatosis with
polyangiitis (Wegener's).
® paranasal sinus pain and drainage and
purulent or bloody nasal discharge, with or
without nasal mucosal ulceration
صفحه 29:
خب ۱7
6 Nasal septal perforation may follow, leading
to saddle nose deformity
© Serous otitis media
© Subglottic tracheal stenosis resulting from
active disease
صفحه 30:
Saddle nose deformity in relapsing polychondritis =
Saddle nose deformity (arrow) due to cartilage damage in a
patient with relay
Courtesy of Clement
صفحه 31:
خب ۱7
® Pulmonary involvement may be manifested as
asymptomatic infiltrates or may be clinically
expressed as cough, hemoptysis, dyspnea,
and chest discomfort. It is present in 85-90%
of patients
صفحه 32:
© Eye involvement (52% of patients) may range
from a mild conjunctivitis to dacryocystitis,
episcleritis, scleritis, granulomatous
sclerouveitis, ciliary vessel vasculitis, and
retroorbital mass lesions leading to proptosis.
صفحه 33:
© Skin lesions (46% of patients) appear as
papules, vesicles, palpable purpura, ulcers, or
subcutaneous nodules
© Renal disease (77% of patients) generally
dominates the clinical picture and, if left
untreated, accounts directly or indirectly for
most of the mortality rate in this disease
صفحه 34:
خب ۱7
© proteinuria, hematuria, and red blood cell
casts, it is clear that once clinically detectable
renal functional impairment occurs
صفحه 35:
® Characteristic laboratory findings include a
markedly elevated erythrocyte sedimentation
rate (ESR), mild anemia and leukocytosis,
mild hypergammaglobulinemia (particularly
of the IgA class), and mildly elevated
rheumatoid factor
صفحه 36:
خب ۱7
© Approximately 90% of patients with active
granulomatosis with polyangiitis (Wegener's)
have a positive antiproteinase-3 ANCA.
© increased incidence of venous thrombotic
events
صفحه 37:
خب ۱7
0899985 tissue offers the highest
diagnostic yield
© Renal biopsy can confirm the presence of
pauci-immune glomerulonephritis
صفحه 38:
© The specificity of a positive antiproteinase-3
ANCA for granulomatosis with polyangiitis
(Wegener's) is very high, especially if active
glomerulonephritis is present.
© However, the presence of ANCA should be
adjunctive and, with rare exceptions, should
not substitute for a tissue diagnosis. False-
positive ANCA titers have been reported in
certain infectious and neoplastic diseases.
صفحه 39:
TERRGCOMRVIOM ASHE IEW EOlyanstis (Wegener's)
symptomatic improvement, with little effect
on the ultimate course of the disease.
© The development of treatment with
cyclophophamide dramatically changed
patient outcome
صفحه 40:
© Treatment of granulomatosis with
polyangiitis (Wegener's) is currently viewed
as having two phases:
® induction, where active disease is put into
remission,
® followed by maintenance. The decision
regarding which agents to use for induction
and maintenance is based upon disease
severity together with individual patient
factors that include contraindication, relapse
history, and comorbidities.
صفحه 41:
خب ۱7
© After 3-6 months of induction treatment,
cyclophosphamide should be stopped and
switched to another agent for remission
maintenance
© methotrexate and azathioprine
صفحه 42:
© In patients who are unable to receive
methotrexate or azathioprine or who have
relapsed through such treatment,
mycophenolate mofetil, 1000 mg twice a day,
may also sustain remission following
cyclophosphamide induction.
صفحه 43:
خب ۱7
© Rituximab Induction for Severe Disease
© TMP-SMX may be of benefit in the treatment
of granulomatosis with polyangiitis
(Wegener's) isolated to the sinonasal tissues
صفحه 44:
»)) »)
i
mc ۳ ۳
صفحه 45:
خب ۱7
© Glomerulonephritis is very common in
microscopic polyangiitis, and pulmonary
capillaritis often occurs.
© The absence of granulomatous inflammation
in microscopic polyangiitis is said to
differentiate it from granulomatosis with
polyangiitis (Wegener's).
صفحه 46:
© The mean age of onset is 57 years of age, and
males are slightly more frequently affected
than females.
© The renal lesion seen in microscopic
polyangiitis is identical to that of
granulomatosis with polyangiitis (Wegener's
صفحه 47:
خب ۱7
©). Like granulomatosis with polyangiitis
(Wegener's), microscopic polyangiitis is
highly associated with the presence of ANCA,
which may play a role in pathogenesis of this
syndrome
صفحه 48:
and Laboratory Manifestations یات
Glomerulonephritis occurs in at least 79% of ©
patients and can be rapidly progressive,
leading to renal failure
© Hemoptysis may be the first symptom of
alveolar hemorrhage
© Other manifestations include mononeuritis
multiplex and gastrointestinal tract and
cutaneousvasculitis.
صفحه 49:
خب ۱7
© Upper airway disease and pulmonary nodules
are not typically found in microscopic
polyangiitis and, if present, suggest
granulomatosis with polyangiitis (Wegener's).
صفحه 50:
® elevated ESR, anemia, leukocytosis, and
thrombocytosis.
© ANCA are present in 75% of patients with
microscopic polyangiitis, with
antimyeloperoxidase antibodies being the
predominant ANCA associated with this
disease.
صفحه 51:
خب ۱7
© The diagnosis is based on histologic evidence
of vasculitis or pauci-immune
glomerulonephritis in a patient with
compatible clinical features of multisystem
disease
صفحه 52:
خب ۱7
6 the treatment approach for microscopic
polyangiitis is the same as is used for
granulomatosis with polyangiitis (Wegener's)
صفحه 53:
۱ i ۳ ۳ i
صفحه 54:
خب ۱7
Churg-Strauss Syndrome
8 Churg-Strauss syndrome, also referred to as
allergic angiitis and granulomatosis
© The mean age of onset is 48 years
® Skin lesions occur in 51% of patients and
include purpura in addition to cutaneous and
subcutaneous nodules
صفحه 55:
خب ۱7
® fever, malaise, anorexia, and weight loss
© The pulmonary findings in Churg-Strauss
syndrome clearly dominate the clinical
picture with severe asthmatic attacks and the
presence of pulmonary infiltrates
صفحه 56:
خب ۱7
® Mononeuritis multiplex is the second most
common manifestation and occurs in up to
72% of patients.
® Allergic rhinitis and sinusitis
® Clinically recognizable heart disease occurs
in 14% of patients and is an important cause
of mortality
صفحه 57:
خب ۱7
© The characteristic laboratory finding in
virtually all patients with Churg-Strauss
syndrome is a striking eosinophilia, which
reaches levels >1000 cells/L in >80% of
patients
صفحه 58:
Eosinophilic granulomatosis with polyangiitis (Churg a
Strauss)
Cutaneous ulceration on the elbow of a patient with eosinophilic
granulomatosis with polyangiitis (Churg-Strauss).
Courtesy of Talmadge E King, Jr, MD.
صفحه 59:
® elevated ESR, fibrinogen, or 2-globulins
® The other laboratory findings reflect the
organ systems involved. Approximately 48%
of patients with Churg-Strauss syndrome
have circulating ANCA that is usually
antimyeloperoxidase.
صفحه 60:
خب ۱7
6 the diagnosis of Churg-Strauss syndrome is
optimally made by biopsy in a patient with
the characteristic clinical manifestations
® Glucocorticoids alone appear to be effective
in many patients.
صفحه 61:
خب ۱7
® In glucocorticoid failure or in patients who
present with fulminant multisystem disease,
the treatment of choice is a combined
regimen of daily cyclophosphamide and
prednisone
صفحه 62:
صفحه 63:
ia ١ 0 ۳ ۳ اس
i ii ۲ I ۱ i 0
ار
صفحه 64:
خب ۱7
® also referred to as classic PAN
© Itis a multisystem, necrotizing vasculitis of
small and medium-sized muscular arteries in
which involvement of the renal and visceral
arteries is characteristic..
صفحه 65:
خب ۱7
© PAN does not involve pulmonary arteries,
although bronchial vessels may be involved;
granulomas, significant eosinophilia, and an
allergic diathesis are not observed
صفحه 66:
خب ۱7
© The vascular lesion in PAN is a necrotizing
inflammation of small and medium-sized
muscular arteries
© The lesions are segmental and tend to involve
bifurcations and branchings of arteries.
صفحه 67:
® Nonspecific signs and symptoms are the
hallmarks of PAN
© Fever, weight loss, and malaise are present in
over one-half of cases
® Patients usually present with vague
symptoms such as weakness, malaise,
headache, abdominal pain, and myalgias that
can rapidly progress to a fulminant illness
صفحه 68:
خب ۱7
® In PAN, renal involvement most commonly
manifests as hypertension, renal insufficiency,
or hemorrhage due to microaneurysms.
صفحه 69:
‘Table 326-6 Clinical Manifestations Related to Organ System Involvement in Classic Polyarteritis Nodosa
‘Clinical Manifestations
al falure, hypertension
|arthiti, arthralgia, myalgia
[Peripheral neuropathy, mononeuritis muitplex
| abdominal pain, uses and vertng, bleeding, bonelinfarcton and perfration,chalecistits,
تسیا
1
| kesh, purpura, nodules, cutaneous infarcts, lvedo reticularis, Raynaud's phenomenon
| congestive heart faiure, myocar-ial infarction, pericarditis
تا ‘ovarian, or epididymal p3in
1
| Cerebral vascular accident, altered mental status, seizure
Percent
Incidence
43
36
25
23
Organ System
Renal
Musculoskeletal
Peripheral nervous
system
Gastrointestinal trect
skin
cardiac
Genitourinary
Central nervous system
صفحه 70:
© The anemia of chronic disease may be seen,
and an elevated ESR is almost always present
© Hypergammaglobulinemia may be present,
and all patients should be screened for
hepatitis B.
© Antibodies against myeloperoxidase or
proteinase-3 (ANCA) are rarely found in
patients with PAN.
صفحه 71:
© The diagnosis of PAN is based on the
demonstration of characteristic findings of
vasculitis on biopsy material of involved
organs
® In the absence of easily accessible tissue for
biopsy, the arteriographic demonstration of
involved vessels, particularly in the form of
aneurysms of small and medium-sized
arteries in the renal, hepatic, and visceral
vasculature, is sufficient to make the
diagnosis.
صفحه 72:
خب ۱7
® Aneurysms of vessels are not pathognomonic
of PAN; furthermore, aneurysms need not
always be present, and arteriographic
findings may be limited to stenotic segments
and obliteration of vessels.
صفحه 73:
۲۱6۷8۲ 38621 Arteriogram of a 40-year-old man with polyarteri-
tis nodosa demonstra s in the hepatic circulation
صفحه 74:
صفحه 75:
® Biopsy of symptomatic organs such as
nodular skin lesions, painful testes, and
nerve/muscle provides the highest diagnostic
yields.
© Death usually results from gastrointestinal
complications, particularly bowel infarcts and
perforation, and cardiovascular causes.
صفحه 76:
خب ۱7
® Intractable hypertension often compounds
dysfunction in other organ systems, such as
the kidneys, heart, and CNS, leading to
additional late morbidity and mortality in PAN
صفحه 77:
خب ۱7
© Favorable therapeutic results have been
reported in PAN with the combination of
prednisone and cyclophosphamide
صفحه 78:
خب ۱7
® In patients with hepatitis B who have a PAN-
like vasculitis, antiviral therapy represents an
important part of therapy and has been used
in combination with glucocorticoids and
plasma exchange.
صفحه 79:
0
صفحه 80:
® Giant cell arteritis, also referred to as cranial
arteritis or temporal arteritis, is an
inflammation of medium- and large-sized
arteries.
© It characteristically involves one or more
branches of the carotid artery, particularly
the temporal artery
صفحه 81:
® it is a systemic disease that can involve
arteries in multiple locations, particularly the
aorta and its main branches.
© Giant cell arteritis is closely associated with
polymyalgia rheumatica, which is
characterized by stiffness, aching, and pain in
the muscles of the neck, shoulders, lower
back, hips, and thighs.
صفحه 82:
® Giant cell arteritis occurs almost exclusively
in individuals >50 years.
© Giant cell arteritis is most commonly
characterized clinically by the complex of
fever, anemia, high ESR, and headaches in a
patient over the age of 50 years.
صفحه 83:
Visibly enlarged temporal artery in a patient with giant cell
arteritis (arrows).
Courtesy of Gene G Hunder, MD.
صفحه 84:
® In patients with involvement of the cranial
arteries, headache is the predominant
symptom and may be associated with a
tender, thickened, or nodular artery, which
may pulsate early in the disease but may
become occluded later.
® Scalp pain and claudication of the jaw and
tongue may occur
صفحه 85:
۲۱608۲ 2860-11 ۵
arteriogram demonstrating a
long stenotic lesion of the axillary artery in a 75-year-old female with
giant cell arteritis.
صفحه 86:
FIGURE386e-12 Magnetic resonance imaging demonstrating
extensive san poet disease ofthe tho
صفحه 87:
© A well-recognized and dreaded complication
of giant cell arteritis, particularly in
untreated patients, is ischemic optic
neuropathy, which may lead to serious visual
symptoms, even sudden blindness in some
patients.
صفحه 88:
® Characteristic laboratory findings in addition
to the elevated ESR include a normochromic
or slightly hypochromic anemia
® Liver function abnormalities are common,
particularly increased alkaline phosphatase
levels.
صفحه 89:
© The diagnosis of giant cell arteritis and its
associated clinicopathologic syndrome can
often be suggested clinically by the
demonstration of the complex of fever,
anemia, and high ESR with or without
symptoms of polymyalgia rheumatica in a
patient >50 years
صفحه 90:
خب ۱7
© The diagnosis is confirmed by biopsy of the
temporal artery
® biopsy segment of 3-5 cm
© Ultrasonography of the temporal artery has
been reported to be helpful in diagnosis
صفحه 91:
® Isolated polymyalgia rheumatica is a clinical
diagnosis made by the presence of typical
symptoms of stiffness, aching, and pain in the
muscles of the hip and shoulder girdle, an
increased ESR, the absence of clinical
features suggestive of giant cell arteritis, and
a prompt therapeutic response to low-dose
prednisone.
صفحه 92:
سس
Treatment: Giant Cell Arteritis and
Polymyalgia ۵
© Giant cell arteritis and its associated
symptoms are exquisitely sensitive to
glucocorticoid therapy
© The ESR can serve as a useful indicator of
inflammatory disease activity in monitoring
and tapering therapy
© Patients with isolated polymyalgia
rheumatica respond promptly to prednisone
صفحه 93:
: 7
i 1 ‘i ۳
۳ "0 0 : ۳) 1 ۲ i) i Mi
صفحه 94:
Takayasu's arteritis
® aortic arch and its branches.
® Pulses are commonly absent in the involved
vessels, particularly the subclavian artery
© Hypertension occurs in 32-93% of patients
and contributes to renal, cardiac, and
cerebral injury.
® Characteristic laboratory findings include an
elevated ESR, mild anemia, and elevated
immunoglobulin levels.
صفحه 95:
FIGURE386e-13 _Arteriogram of the aortic arch demonstrating
complete occlusion of the left common carotid artery just af
origin from the aorta. This 20-year-old female presented with syncope
and was subsequently diagnosed with Takayasu arteritis.
صفحه 96:
خب ۱7
© The diagnosis of Takayasu's arteritis should
be suspected strongly in a young woman who
develops a decrease or absence of peripheral
pulses, discrepancies in blood pressure, and
arterial bruits.
صفحه 97:
خب ۱7
® the characteristic pattern on arteriography,
which includes irregular vessel walls,
stenosis, poststenotic dilation, aneurysm.
formation, occlusion, and evidence of
increased collateral circulation
صفحه 98:
خب ۱7
© The combination of glucocorticoid therapy for
acute signs and symptoms and an aggressive
surgical and/or arterioplastic approach to
stenosed vessels has markedly improved
outcome and decreased morbidity by
lessening the risk of stroke, correcting
hypertension due to renal artery stenosis, and
improving blood flow to ischemic viscera and
limbs.
صفحه 99:
۱۳
اا
صفحه 100:
Purpura
® also referred to as anaphylactoid purpura
® palpable purpura (most commonly distributed
over the buttocks and lower extremities),
arthralgias, gastrointestinal signs and
symptoms, and glomerulonephritis
صفحه 101:
© most patients range in age from 4 to 7 years;
however, the disease may also be seen in
infants and adults
® by colicky abdominal pain usually associated
with nausea, vomiting, diarrhea, or
constipation and is frequently accompanied
by the passage of blood and mucus per
rectum; bowel intussusception
صفحه 102:
Petechiae in Henoch-Schénlein purpura (IgA vascu تحص رن
Clusters of palpable, pruritic petechiae on the thigh of a patient
with Henoch-Schénlein purpura (IgA vasculitis). These lesions
could be mistaken for thrombocytopenic petechiae.
صفحه 103:
Skin manifestations of Henoch-
vasculitis)
hénlein purpura (IgA
This picture shows the classic skin manifestations of Henoch-Schoniein
purpure (IgA vasculitis), with clusters of typical ecchymoses, petechiae,
and palpable lesions on the legs in a typical distribution
(gravity/pressure-dependent areas),
Courtesy of Susan Kim, MD.
صفحه 104:
خب ۱7
© proteinuria and microscopic hematuria, with
red blood cell casts
© Serum complement components are normal,
and IgA levels are elevated in about one-half
of patients.
صفحه 105:
® The diagnosis of Henoch-Schénlein purpura
is based on clinical signs and symptoms.
© Skin biopsy specimen can be useful in
confirming leukocytoclastic vasculitis with
IgA and C3 deposition by
immunofluorescence
صفحه 106:
خب ۱7
© The prognosis of Henoch-Schonlein purpura
is excellent.
© glucocorticoid therapy
® plasma exchange combined with cytotoxic
drugs
صفحه 107:
صفحه 108:
هت
6
ryoglobulinemic Vasculitis
® systemic vasculitis characterized by palpable
purpura, arthralgias, weakness, neuropathy,
and glomerulonephritis
® in association with a variety of underlying
disorders including multiple myeloma,
lymphoproliferative disorders, connective
tissue diseases, infection, and liver disease
صفحه 109:
Leucocytoclastic vasc
Leukocytoclastic vasculitis appearing as raised purpura. This
lesion can occur with any vasculitic syndrome and in the collagen
vascular diseases.
Courtesy of Marvin I Schwarz, MD.
صفحه 110:
خب ۱7
® chronic hepatitis C
© The most common clinical manifestations of
cryoglobulinemic vasculitis are cutaneous
vasculitis, arthritis, peripheral neuropathy,
and glomerulonephritis
صفحه 111:
FIGURE 386e-15 Arteriogram of the hand der
kip lesion v na patient with
صفحه 112:
خب ۱7
© Rheumatoid factor is almost always found
and may be a useful clue to the disease when
cryoglobulins are not detected
© Hypocomplementemia occurs in 90%
® elevated ESR and anemia
صفحه 113:
خب ۱7
® the majority of cases are associated with
hepatitis C infection. In such patients,
treatment with IFN- and ribavirin
® Glucocorticoids
© Plasmapheresis and cytotoxic agents
صفحه 114:
Isolated Vasculitis
صفحه 115:
Isolated Vasculitis of the Central Nervous System
® restricted to the vessels of the CNS without
other apparent systemic vasculitis
© altered mental function, and focal neurologic
defects
® Systemic symptoms are generally absent
صفحه 116:
® abnormal MRI of the brain, an abnormal
lumbar puncture, and/or demonstration of
characteristic vessel abnormalities on
arteriography
© The prognosis of granulomatous PACNS is
poor
® glucocorticoid therapy, alone or together with
cyclophosphamide
صفحه 117:
صفحه 118:
FIGURE 386e-10 Cerebral arteriogram demonstrating beading
along branches of the internal carotid artery v
صفحه 119:
0 0
(i
۳
صفحه 120:
9 Disease a
® also referred to as mucocutaneous lymph
node syndrome
® an acute, febrile, multisystem disease of
children
© Some 80% of cases occur prior to the age of
5
صفحه 121:
® nonsuppurative cervical adenitis and changes
in the skin and mucous membranes such as
edema; congested conjunctivae; erythema of
the oral cavity, lips, and palms; and
desquamation of the skin of the fingertips.
صفحه 122:
® coronary artery aneurysms
© These complications usually occur between
the third and fourth weeks of illness during
the convalescent stage
© Other manifestations include pericarditis,
myocarditis, myocardial ischemia and
infarction, and cardiomegaly.
صفحه 123:
Courtesy of Robert Sundel, MD.
صفحه 124:
. Copyright Logical Images, Inc.
صفحه 125:
_ Strawberry tongue
Reproduced with permission from: vwa.visualdx.com. Copyright Logical
images, Inc
صفحه 126:
Indurated edema of the dorsum of the hands as seen a
Kawasaki disease (acute phase)
Reproduced with permission from: ww jaldx.com. Copyright Logical Images, Inc.
صفحه 127:
iste perungual desquamation of the hands: a
and feet seen in Kawasaki disease
صفحه 128:
® High-dose IV globulin (2 g/kg as a single
infusion over 10 h) together with aspirin (100
mg/kg per day for 14 days followed by 3-5
mg/kg per day for several weeks)
® Surgery may be necessary for Kawasaki
disease patients that have giant coronary
artery aneurysms or other coronary
complications
صفحه 129:
د 0 0 |
C »